Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.03.2019 | Case report

Icotinib

Development of resistance in pulmonary adenocarcinoma: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Han C, et al. Small-cell lung cancer transformation in a pulmonary adenocarcinoma patient as an acquired resistance mechanism to icotinib: A case report and review. International Journal of Clinical and Experimental Medicine 12: 1086-1093, No. 1, 2019. Available from: URL: http://www.ijcem.com/files/ijcem0076906.pdf - China Han C, et al. Small-cell lung cancer transformation in a pulmonary adenocarcinoma patient as an acquired resistance mechanism to icotinib: A case report and review. International Journal of Clinical and Experimental Medicine 12: 1086-1093, No. 1, 2019. Available from: URL: http://​www.​ijcem.​com/​files/​ijcem0076906.​pdf - China
Metadaten
Titel
Icotinib
Development of resistance in pulmonary adenocarcinoma: case report
Publikationsdatum
01.03.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-59048-2

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Temozolomide

Case report

Interferon-β-1a

Case report

Eltrombopag

Case report

Gelatin

Case report

Qingdai-compound